InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: A deleted message

Thursday, 12/14/2017 7:35:42 PM

Thursday, December 14, 2017 7:35:42 PM

Post# of 48316
Market might not be excited about a single patient starting treatment. More patients may be enrolled now but haven't been dosed yet. The negative price action on the news might have the market nervous about getting data by mid 2018. Might be more realistic to expect data by end of 2018 on fully enrolled and treated 23 patients of first phase of trial. Any price weakness going into 2018 is a great buying opportunity in my opinion.